[PHARMA] YoY Quarter Result on 31-Dec-2014 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 145.38%
YoY- 76.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 613,196 582,816 680,150 627,103 567,860 482,404 367,786 8.88%
PBT 19,866 4,069 23,717 37,854 33,007 4,248 16,368 3.27%
Tax 2,222 -4,969 -7,676 -1,233 -11,740 -11,716 -4,186 -
NP 22,088 -900 16,041 36,621 21,267 -7,468 12,182 10.41%
-
NP to SH 21,700 -836 16,062 36,697 20,813 -7,934 11,942 10.45%
-
Tax Rate -11.18% 122.12% 32.36% 3.26% 35.57% 275.80% 25.57% -
Total Cost 591,108 583,716 664,109 590,482 546,593 489,872 355,604 8.83%
-
Net Worth 526,888 531,169 529,786 525,351 486,672 472,037 514,153 0.40%
Dividend
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Div 15,573 7,773 18,134 31,055 16,049 11,771 35,296 -12.73%
Div Payout % 71.77% 0.00% 112.90% 84.63% 77.11% 0.00% 295.57% -
Equity
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Net Worth 526,888 531,169 529,786 525,351 486,672 472,037 514,153 0.40%
NOSH 259,821 259,377 259,064 258,794 258,868 117,715 117,655 14.10%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 3.60% -0.15% 2.36% 5.84% 3.75% -1.55% 3.31% -
ROE 4.12% -0.16% 3.03% 6.99% 4.28% -1.68% 2.32% -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 236.25 224.93 262.54 242.32 219.36 409.81 312.60 -4.55%
EPS 8.36 -0.32 6.20 14.18 8.04 -6.74 10.15 -3.17%
DPS 6.00 3.00 7.00 12.00 6.20 10.00 30.00 -23.50%
NAPS 2.03 2.05 2.045 2.03 1.88 4.01 4.37 -11.98%
Adjusted Per Share Value based on latest NOSH - 258,794
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 42.55 40.44 47.19 43.51 39.40 33.47 25.52 8.88%
EPS 1.51 -0.06 1.11 2.55 1.44 -0.55 0.83 10.47%
DPS 1.08 0.54 1.26 2.15 1.11 0.82 2.45 -12.75%
NAPS 0.3656 0.3685 0.3676 0.3645 0.3377 0.3275 0.3567 0.41%
Price Multiplier on Financial Quarter End Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 -
Price 4.60 5.30 6.36 4.58 4.45 8.10 5.36 -
P/RPS 1.95 2.36 2.42 1.89 2.03 1.98 1.71 2.21%
P/EPS 55.02 -1,642.66 102.58 32.30 55.35 -120.18 52.81 0.68%
EY 1.82 -0.06 0.97 3.10 1.81 -0.83 1.89 -0.62%
DY 1.30 0.57 1.10 2.62 1.39 1.23 5.60 -21.58%
P/NAPS 2.27 2.59 3.11 2.26 2.37 2.02 1.23 10.74%
Price Multiplier on Announcement Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 27/02/18 21/02/17 15/02/16 23/02/15 24/02/14 18/02/13 22/02/12 -
Price 4.04 5.12 6.19 5.28 4.29 7.80 5.90 -
P/RPS 1.71 2.28 2.36 2.18 1.96 1.90 1.89 -1.65%
P/EPS 48.32 -1,586.88 99.84 37.24 53.36 -115.73 58.13 -3.03%
EY 2.07 -0.06 1.00 2.69 1.87 -0.86 1.72 3.13%
DY 1.49 0.59 1.13 2.27 1.45 1.28 5.08 -18.47%
P/NAPS 1.99 2.50 3.03 2.60 2.28 1.95 1.35 6.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment